Videos

Brian Torres of Herspiegel Consulting explains the recent shift in patient support programs and how that will influence the future of Pharma. 

The Evolution of Patient Services

At a time when life sciences companies have seen an unprecedented acceleration in the adoption of digital tools, many are now faced with managing a myriad of tools and applications with varying levels of security and technology requirements. Biopharma and medical device manufacturers are now exploring solutions and platforms that can provide the stability, regulatory compliance, and end-to-end connectivity needed to design, deliver and scale digital solutions that deliver clinical and economic benefits to patients, providers and payers.  In this session, Brian Williams, Chief Digital Officer for Life Sciences at Cognizant, will discuss the opportunity available to digital-first companies that are considering cloud platforms like Philips HealthSuite, which is built on Amazon Web Services. 

Enabling Transformation in Life Sciences Through Digital Health Solutions

This video series discusses the impact of implementing risk-based quality management (RBQM) and decentralized clinical trials (DCTs) from the clinical operations point of view.

Practically Speaking: Driving Clinical Transformation 

As the initial COVID-19 pandemic begins to resolve in the form of vaccines and treatment pathways, research into the long-term effects of COVID is building. In response, in December, Congress provided $1.15 billion in funding over four years for NIH to support research into the prolonged health consequences of SARS-CoV-2 infection. This roundtable of experts from various stakeholder groups will discuss the current research into long-haul COVID, or PASC; disparate theories of causes; challenges in research and diagnosis, as well as PASC potential in drug development.

Studying Long COVID in Drug Development

Roundtable: Synthetic Control Arms and Regulatory/HTA Requirements

In a recent virtual roundtable discussion, industry experts Jim Streeter, Alison Holland, Hassan Kadhim, Craig Lipset, Josh Rose, and Craig Serra shared their insight on the challenges faced in implementing decentralized trials and how to address them. Along with the roundtable are video discussions covering the cost and feasibility of a toolkit approach to decentralized trials, the significance of minimizing burden to patients and sites, and the reality of regulatory hurdles.

Sponsored Videos